Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM189A1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
mRNA | ERCC6L | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
mRNA | CTD-3105H18.18 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | HAUS2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
mRNA | SSH3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | ZNF546 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | ZNF594 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | CNOT8 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
mRNA | GAGE12D | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
mRNA | GPAT3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |